FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:231-232 January 16, 1997 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

By Michael D. Green. 368 pp. Philadelphia, University of Pennsylvania Press, 1996. $29.95. ISBN 0-8122-3257-7.

Litigation concerning mass toxic substances (i.e., substances affecting many thousands of people) has become a permanent feature of the medical landscape, in no small measure as a result of the rise and fall of Bendectin. Michael Green, a professor of law at the University of Iowa, tells the scientific, clinical, and legal story of Bendectin by chronicling the case of Mekdeci v. Merrell National Laboratories, from David Mekdeci's birth in 1975 with anomalies his mother thought were due to Bendectin, to the 1980 trial in which the Mekdecis were awarded only $20,000 in an equivocal decision by the jury, to . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.